Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06256575

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Led by Primus Pharmaceuticals · Updated on 2025-12-04

45

Participants Needed

5

Research Sites

119 weeks

Total Duration

On this page

Sponsors

P

Primus Pharmaceuticals

Lead Sponsor

K

KGK Science Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is performed to consider the safety and healing ability of diosmin in patients with systemic sclerosis (scleroderma) and open sores on their fingers (digital ulcers). Two (2) out of three (3) participants will receive active product. The participants will have four (4) visits over eight (8) weeks. Physical exams and photos will be performed. A variety of questions will be asked describing level of pain and lifestyle changes.

CONDITIONS

Official Title

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of systemic sclerosis (scleroderma)
  • At least one "active" digital ulcer
  • Medication for systemic sclerosis unchanged for 30 days
Not Eligible

You will not qualify if you...

  • Infection or gangrene in ulcer
  • Citrus allergy
  • Unstable heart, kidney, or liver disease
  • Active infection of any type
  • Current cancer treatment or uncured cancer
  • Pregnancy or breast feeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

University of Calgary

Calgary, Alberta, Canada, T2N 1N4

Actively Recruiting

2

Dalhousie University

Halifax, Nova Scotia, Canada, B3H 4K4

Not Yet Recruiting

3

Saint Joseph Health Care Centre

London, Ontario, Canada, N6A 4V2

Actively Recruiting

4

The Ottawa Hospital

Ottawa, Ontario, Canada, K1H 7W9

Actively Recruiting

5

Mount Sinai Health System

Toronto, Ontario, Canada, M5T 3L9

Actively Recruiting

Loading map...

Research Team

L

Lukban

CONTACT

M

Mary L Sanstead

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here